Journal
Clincal Genitourinary Cancer
Publication Date
2-1-2022
Volume
20
Issue
1
First Page
1
Last Page
10
Document Type
Open Access Publication
DOI
10.1016/j.clgc.2021.07.002
Rights and Permissions
Costello BA, Bhavsar NA, Zakharia Y, Pal SK, Vaishampayan U, Jim H, Fishman MN, Molina AM, Kyriakopoulos CE, Tsao CK, Appleman LJ, Gartrell BA, Hussain A, Stadler WM, Agarwal N, Pachynski RK, Hutson TE, Hammers HJ, Ryan CW, Mardekian J, Borham A, George DJ, Harrison MR. A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience. Clin Genitourin Cancer. 2022 Feb;20(1):1-10. doi: 10.1016/j.clgc.2021.07.002. © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Costello, Brian A.; Pachynski, Russell K.; and et al., "A prospective multicenter evaluation of initial treatment choice in metastatic renal cell carcinoma prior to the immunotherapy era: The MaRCC Registry experience." Clincal Genitourinary Cancer. 20, 1. 1 - 10. (2022).
https://digitalcommons.wustl.edu/oa_4/1638
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
